rs3766871

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_001035.3(RYR2):​c.5656G>A​(p.Gly1886Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0374 in 1,609,148 control chromosomes in the GnomAD database, including 1,711 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1886A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.061 ( 447 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1264 hom. )

Consequence

RYR2
NM_001035.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 3.45

Publications

45 publications found
Variant links:
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]
RYR2 Gene-Disease associations (from GenCC):
  • arrhythmogenic right ventricular dysplasia 2
    Inheritance: AD Classification: DEFINITIVE, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Ambry Genetics
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • catecholaminergic polymorphic ventricular tachycardia 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the RYR2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 195 curated pathogenic missense variants (we use a threshold of 10). The gene has 55 curated benign missense variants. Gene score misZ: 5.7809 (above the threshold of 3.09). Trascript score misZ: 6.4158 (above the threshold of 3.09). GenCC associations: The gene is linked to hypertrophic cardiomyopathy, catecholaminergic polymorphic ventricular tachycardia 1, catecholaminergic polymorphic ventricular tachycardia, arrhythmogenic right ventricular dysplasia 2, arrhythmogenic right ventricular cardiomyopathy.
BP4
Computational evidence support a benign effect (MetaRNN=0.002141565).
BP6
Variant 1-237614784-G-A is Benign according to our data. Variant chr1-237614784-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 36747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR2NM_001035.3 linkc.5656G>A p.Gly1886Ser missense_variant Exon 37 of 105 ENST00000366574.7 NP_001026.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR2ENST00000366574.7 linkc.5656G>A p.Gly1886Ser missense_variant Exon 37 of 105 1 NM_001035.3 ENSP00000355533.2
RYR2ENST00000661330.2 linkc.5656G>A p.Gly1886Ser missense_variant Exon 37 of 106 ENSP00000499393.2
RYR2ENST00000609119.2 linkn.5656G>A non_coding_transcript_exon_variant Exon 37 of 104 5 ENSP00000499659.2

Frequencies

GnomAD3 genomes
AF:
0.0603
AC:
9178
AN:
152122
Hom.:
436
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0320
Gnomad ASJ
AF:
0.0236
Gnomad EAS
AF:
0.0728
Gnomad SAS
AF:
0.0453
Gnomad FIN
AF:
0.0215
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0284
Gnomad OTH
AF:
0.0532
GnomAD2 exomes
AF:
0.0404
AC:
9914
AN:
245230
AF XY:
0.0391
show subpopulations
Gnomad AFR exome
AF:
0.143
Gnomad AMR exome
AF:
0.0195
Gnomad ASJ exome
AF:
0.0196
Gnomad EAS exome
AF:
0.0813
Gnomad FIN exome
AF:
0.0245
Gnomad NFE exome
AF:
0.0306
Gnomad OTH exome
AF:
0.0361
GnomAD4 exome
AF:
0.0350
AC:
51011
AN:
1456908
Hom.:
1264
Cov.:
32
AF XY:
0.0351
AC XY:
25385
AN XY:
724032
show subpopulations
African (AFR)
AF:
0.149
AC:
4962
AN:
33276
American (AMR)
AF:
0.0216
AC:
960
AN:
44456
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
484
AN:
25920
East Asian (EAS)
AF:
0.0669
AC:
2651
AN:
39614
South Asian (SAS)
AF:
0.0418
AC:
3589
AN:
85914
European-Finnish (FIN)
AF:
0.0269
AC:
1433
AN:
53246
Middle Eastern (MID)
AF:
0.0381
AC:
218
AN:
5728
European-Non Finnish (NFE)
AF:
0.0309
AC:
34225
AN:
1108612
Other (OTH)
AF:
0.0414
AC:
2489
AN:
60142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2892
5785
8677
11570
14462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1396
2792
4188
5584
6980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0606
AC:
9226
AN:
152240
Hom.:
447
Cov.:
32
AF XY:
0.0591
AC XY:
4400
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.139
AC:
5778
AN:
41526
American (AMR)
AF:
0.0319
AC:
488
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0236
AC:
82
AN:
3468
East Asian (EAS)
AF:
0.0722
AC:
373
AN:
5168
South Asian (SAS)
AF:
0.0450
AC:
217
AN:
4826
European-Finnish (FIN)
AF:
0.0215
AC:
228
AN:
10626
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0284
AC:
1929
AN:
68020
Other (OTH)
AF:
0.0550
AC:
116
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
419
838
1257
1676
2095
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0387
Hom.:
905
Bravo
AF:
0.0645
TwinsUK
AF:
0.0294
AC:
109
ALSPAC
AF:
0.0363
AC:
140
ESP6500AA
AF:
0.129
AC:
515
ESP6500EA
AF:
0.0311
AC:
259
ExAC
AF:
0.0425
AC:
5144
Asia WGS
AF:
0.0760
AC:
264
AN:
3478
EpiCase
AF:
0.0302
EpiControl
AF:
0.0315

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Jul 20, 2016
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 23, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 20, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25773045, 30403697, 27153395, 27663074, 18326664, 19926015, 20408814, 24025405) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cardiomyopathy Benign:2
Mar 01, 2013
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 15, 2018
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Catecholaminergic polymorphic ventricular tachycardia Benign:1
Oct 01, 2024
All of Us Research Program, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arrhythmogenic right ventricular cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
15
DANN
Benign
0.95
DEOGEN2
Benign
0.33
T;T
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.76
D
LIST_S2
Benign
0.84
T;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N;.
PhyloP100
3.4
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.92
N;.
REVEL
Benign
0.094
Sift
Benign
0.34
T;.
Polyphen
0.0020
B;.
Vest4
0.076
MPC
0.36
ClinPred
0.012
T
GERP RS
4.8
Varity_R
0.10
gMVP
0.071
Mutation Taster
=65/35
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3766871; hg19: chr1-237778084; COSMIC: COSV63687181; API